BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11390004)

  • 1. Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort.
    Marshall D; Simpson KN; Earle CC; Chu C
    Lung Cancer; 2001 Jun; 32(3):227-36. PubMed ID: 11390004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost-effectiveness of low-dose CT screening for lung cancer: preliminary results of baseline screening.
    Wisnivesky JP; Mushlin AI; Sicherman N; Henschke C
    Chest; 2003 Aug; 124(2):614-21. PubMed ID: 12907551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic decision analysis model of screening for lung cancer.
    Marshall D; Simpson KN; Earle CC; Chu CW
    Eur J Cancer; 2001 Sep; 37(14):1759-67. PubMed ID: 11549429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
    Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis.
    Mahadevia PJ; Fleisher LA; Frick KD; Eng J; Goodman SN; Powe NR
    JAMA; 2003 Jan; 289(3):313-22. PubMed ID: 12525232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis.
    Das P; Ng AK; Earle CC; Mauch PM; Kuntz KM
    Ann Oncol; 2006 May; 17(5):785-93. PubMed ID: 16500905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of implementing computed tomography screening for lung cancer in Taiwan.
    Yang SC; Lai WW; Lin CC; Su WC; Ku LJ; Hwang JS; Wang JD
    Lung Cancer; 2017 Jun; 108():183-191. PubMed ID: 28625633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of Lung Cancer Screening in Canada.
    Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
    JAMA Oncol; 2015 Sep; 1(6):807-13. PubMed ID: 26226181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of lung MRI in lung cancer screening.
    Allen BD; Schiebler ML; Sommer G; Kauczor HU; Biederer J; Kruser TJ; Carr JC; Hazen G
    Eur Radiol; 2020 Mar; 30(3):1738-1746. PubMed ID: 31748855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
    Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
    Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of CT screening in the National Lung Screening Trial.
    Black WC; Gareen IF; Soneji SS; Sicks JD; Keeler EB; Aberle DR; Naeim A; Church TR; Silvestri GA; Gorelick J; Gatsonis C;
    N Engl J Med; 2014 Nov; 371(19):1793-802. PubMed ID: 25372087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of chest computed tomography after lung cancer resection: a decision analysis model.
    Kent MS; Korn P; Port JL; Lee PC; Altorki NK; Korst RJ
    Ann Thorac Surg; 2005 Oct; 80(4):1215-22; discussion 1222-3. PubMed ID: 16181843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose chest computed tomography for lung cancer screening among Hodgkin lymphoma survivors: a cost-effectiveness analysis.
    Wattson DA; Hunink MG; DiPiro PJ; Das P; Hodgson DC; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):344-53. PubMed ID: 25104066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-utility analysis of a potential lung cancer screening program for a high-risk population in Germany: A modelling approach.
    Hofer F; Kauczor HU; Stargardt T
    Lung Cancer; 2018 Oct; 124():189-198. PubMed ID: 30268459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness of colorectal cancer screening in the elderly.
    Wagner JL; Herdman RC; Wadhwa S
    Ann Intern Med; 1991 Nov; 115(10):807-17. PubMed ID: 1929029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of the introduction of low-dose CT screening in Japanese smokers aged 55 to 74 years old.
    Tabata H; Akita T; Matsuura A; Kaishima T; Matsuoka T; Ohisa M; Awai K; Tanaka J
    Hiroshima J Med Sci; 2014 Sep; 63(1-3):13-22. PubMed ID: 25735063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of baseline low-dose computed tomography screening for lung cancer: the Israeli experience.
    Shmueli A; Fraifeld S; Peretz T; Gutfeld O; Gips M; Sosna J; Shaham D
    Value Health; 2013; 16(6):922-31. PubMed ID: 24041342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking-A modelling study.
    Tomonaga Y; Ten Haaf K; Frauenfelder T; Kohler M; Kouyos RD; Shilaih M; Lorez M; de Koning HJ; Schwenkglenks M; Puhan MA
    Lung Cancer; 2018 Jul; 121():61-69. PubMed ID: 29858029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of lung cancer screening in Japan.
    Okamoto N
    Cancer; 2000 Dec; 89(11 Suppl):2489-93. PubMed ID: 11147633
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.